AI assistant
IONEER LTD — Capital/Financing Update 2017
Sep 7, 2017
65129_rns_2017-09-07_69988209-9ede-43dd-bc44-26eaa76fa8f6.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [158 x 54] intentionally omitted <==
8[th] September 2017
ASX Market Announcements ASX Limited Level 6, Exchange Centre 20 Bridge Street SYDNEY NSW 2000
ASX Code: GSC
Vesting of Class B Performance Rights
The Board of Global Geoscience Limited advises that the vesting conditions as set out in the Company’s Performance Rights Plan in relation to the Class B Performance Rights have been satisfied and the Company will issue fully paid ordinary shares in the Company to the registered holders of the Class B Performance Rights.
As disclosed in the Performance Rights Plan and the Notice of Annual General Meeting, the Class B Performance Rights vest upon the Company’s ordinary shares achieving a 10 day VWAP of $0.20. The Company’s shares achieved a 10 day VWAP in excess of $0.20, on 23[rd] August 2017.
The corresponding Appendix 3B and Appendix 3Y in relation to the ordinary shares issued to Mr Bernard Rowe and Mr Patrick Elliott are attached to this announcement.
Yours Faithfully
==> picture [93 x 57] intentionally omitted <==
Joanna Morbey Company Secretary Global Geoscience Limited (Company)
Global Geoscience Ltd ABN 76 098 564 606 Suite 203, 161 Walker Street NORTH SYDNEY NSW 2060 AUSTRALIA
Tel: +61 (2) 9922-5800 Fax: +61 (2) 9922-4004 e-mail: [email protected] Web: www.globalgeo.com.au
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
GLOBAL GEOSCIENCE LIMITED
ABN
76 098 564 606
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
| 1 +Class of+securities issued or to be issued 2 Number of+securities issued or to be issued (if known) or maximum number which may be issued 3 Principal terms of the +securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) |
Ordinary fully paid shares |
|---|---|
| 14,000,000 Ordinary fully paid shares | |
| Ordinary fully paid shares |
- See chapter 19 for defined terms.
Appendix 3B Page 1
04/03/2013
| 4 Do the+securities rank equally in all respects from the+issue date with an existing+class of quoted+securities? If the additional+securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration 6 Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) 6a Is the entity an+eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the+securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder resolution under rule 7.1A was passed 6c Number of+securities issued without security holder approval under rule 7.1 |
Yes, the ordinary shares will rank equally with the existing ordinary shares. |
|---|---|
| Nil consideration – conversion of Class B Performance Rights |
|
| The issue of the ordinary shares is a result of the milestones set for the Class B Performance Rights being met. The terms and conditions of the Performance Rights were disclosed to the ASX on 25th October 2016 in the Company’s Notice of Annual General Meeting. The Global Geoscience Limited Performance Rights Plan was approved by the shareholders of the Company at the Annual General Meeting held on 25thNovember 2016. |
|
| Yes | |
| 25thNovember 2016 | |
| Nil |
| 6d Number of+securities issued with security holder approval under rule 7.1A 6e Number of+securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of+securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If+securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. |
Nil |
|---|---|
| Nil | |
| 17,000,000 Class A Performance Rights – now vested 17,000,000 Class B Performance Rights – 3,000,000 cancelled 17,000,000 Class C Performance Rights – 3,000,000 cancelled |
|
N/A |
|
| N/A | |
| Attached | |
| 8thSeptember 2017 |
Number +Class 8 Number and +class of all 1,155,985,087 Ordinary fully paid +securities quoted on ASX shares ( including the +securities in section 2 if applicable)
- See chapter 19 for defined terms.
Appendix 3B Page 3
04/03/2013
| 9 Number and +class of all +securities not quoted on ASX (_including_the +securities in section 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) |
Number | +Class |
|---|---|---|
| 2,000,000 4,300,000 2,500,000 10,000,000 2,500,000 2,500,000 2,500,000 2,500,000 14,000,000 1,500,000 1,000,000 16,000,000 12,000,000 12,000,000 400,000 400,000 200,000 |
Options expiring 30-Dec-2017 ex 4.7c [GSCAM] Options expiring 30-Dec-2017 ex 7.0c [GSCAQ] Options expiring 2-Sept-2018 ex 10.0c [GSCAR] Options expiring 2-Sept-2018 ex 20.0c [GSCAR] Options expiring 30-Jan-2019 ex 12.5c [GSCAR] Options expiring 30-Jan-2019 ex 15.0c [GSCAR] Options expiring 30-Jan-2019 ex 17.5c [GSCAR] Options expiring 30-Jan-2019 ex 20.0c [GSCAR] Class C Performance Rights [GSCAA] As at the date of this announcement, none of the conditions have been met in relation to these Performance Rights. Options expiring 30-Jan-2019 ex 15.0c [GSCAR] Options expiring 30-Jan-2019 ex 20.0c [GSCAR] Options expiring 13-April-2022 ex 15.0c [GSCAR] Options expiring 13-April-2022 ex 20.0c [GSCAR] Options expiring 13-April-2022 ex 25.0c [GSCAR] Options exercisable at $0.20 after 23 May 2018 [GSCAR] Options exercisable at $0.20 after 23 May 2019 [GSCAR] Options exercisable at $0.20 after 23 May 2020 [GSCAR] |
|
| Dividend policy will remain as currently stated. |
Part 2 - Pro rata issue
| 11 | Is security holder approval |
|---|---|
| required? | |
| 12 | Is the issue renounceable or non- |
| renounceable? | |
| 13 | Ratio in which the+securities |
| will be offered | |
| 14 | +Class of+securities to which the |
| offer relates | |
| 15 | +Record date to determine |
| entitlements | |
| 16 | Will holdings on different |
| registers (or subregisters) be | |
| aggregated for calculating |
|
| entitlements? | |
| 17 | Policy for deciding entitlements |
| in relation to fractions | |
| 18 | Names of countries in which the |
| entity has security holders who | |
| will not be sent new offer | |
| documents | |
| Note: Security holders must be told how their | |
| entitlements are to be dealt with. | |
| Cross reference: rule 7.7. | |
| 19 | Closing date for receipt of |
| acceptances or renunciations | |
| 20 | Names of any underwriters |
| 21 | Amount of any underwriting fee |
| or commission |
- See chapter 19 for defined terms.
Appendix 3B Page 5
04/03/2013
| 22 | Names of any brokers to the |
|---|---|
| issue | |
| 23 | Fee or commission payable to the |
| broker to the issue | |
| 24 | Amount of any handling fee |
| payable to brokers who lodge | |
| acceptances or renunciations on | |
| behalf of security holders | |
| 25 | If the issue is contingent on |
| security holders’ approval, the | |
| date of the meeting | |
| 26 | Date entitlement and acceptance |
| form and offer documents will be | |
| sent to persons entitled | |
| 27 | If the entity has issued options, |
| and the terms entitle option | |
| holders to participate on |
|
| exercise, the date on which | |
| notices will be sent to option | |
| holders | |
| 28 | Date rights trading will begin (if |
| applicable) | |
| 29 | Date rights trading will end (if |
| applicable) | |
| 30 | How do security holders sell |
| their entitlements_in full_through | |
| a broker? | |
| 31 | How do security holders sell_part_ |
| of their entitlements through a | |
| broker and accept for the |
|
| balance? | |
| 32 | How do security holders dispose |
| of their entitlements (except by | |
| sale through a broker)? | |
| 33 | +Issue date |
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
-
34 Type of[+] securities ( tick one )
-
(a) X +Securities described in Part 1
-
(b) All other[+] securities
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
-
35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders
-
36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over
-
37 A copy of any trust deed for the additional[+] securities
Entities that have ticked box 34(b)
-
38 Number of[+] securities for which +quotation is sought
-
39 +Class of +securities for which quotation is sought
- See chapter 19 for defined terms.
Appendix 3B Page 7
04/03/2013
-
40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: • the date from which they do • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
-
• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)
Number +Class 42 Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)
Quotation agreement
-
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.
-
2 We warrant the following to ASX.
-
The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.
-
There is no reason why those[+] securities should not be granted +quotation.
-
An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-
Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.
-
If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.
-
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
-
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
==> picture [91 x 56] intentionally omitted <==
Sign here: Company Secretary Joanna Elizabeth Morbey
Date: 8th September 2017
- See chapter 19 for defined terms.
Appendix 3B Page 9
04/03/2013
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
==> picture [443 x 514] intentionally omitted <==
----- Start of picture text -----
Insert number of fully paid [+] ordinary 1,011,493,922
securities on issue 12 months before the
+ issue date or date of agreement to issue
Add the following:
• Number of fully paid + ordinary securities
issued in that 12 month period under an
exception in rule 7.2
- 24 [th] April 2017 17,000,000
- 8 [th] September 2017 ( the subject of
14,000,000
this Appendix 3B)
• Number of fully paid + ordinary securities
issued in that 12 month period with
shareholder approval
- 6 October 2016 50,000,000
-
18 January 2017 214,285
- 22 March 2017 80,000
-
17 July 2017 11,031,440
• Shares issued pursuant to listed
4,665,440
options being exercised
• Shares issued pursuant to unlisted
5,400,000
options being exercised
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the
securities the subject of the Appendix 3B
to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
----- End of picture text -----
| Subtractthe number of fully paid+ordinary securities cancelled during that 12 month period |
0 |
| “A” | 1,113,885,087 |
| Step 2: Calculate 15% of “A” | |
| “B” | 0.15 [Note: this value cannot be changed] |
| Multiply“A” by 0.15 | 167,082,763 |
| Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items |
|
| “C” | - |
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 |
|
| “A” x 0.15 Note: number must be same as shown in Step 2 |
167,082,763 |
| Subtract“C” Note: number must be same as shown in Step 3 |
- |
- See chapter 19 for defined terms.
Appendix 3B Page 11
04/03/2013
Total [“A” x 0.15] – “C”
167,082,763
[Note: this is the remaining placement capacity under rule 7.1]
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
| Rule 7.1A – Additional placement capacity for eligible entities | Rule 7.1A – Additional placement capacity for eligible entities |
|---|---|
| Step 1: Calculate “A”, the base figure from which the placement capacity is calculated |
|
| “A” Note: number must be same as shown in Step 1 of Part 1 |
1,113,885,087 |
| Step 2: Calculate 10% of “A” | |
| “D” | 0.10 Note: this value cannot be changed |
| Multiply“A” by 0.10 | 111,388,509 |
| Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items |
0 |
| “E” | 0 |
| Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A |
|
| “A” x 0.10 Note: number must be same as shown in Step 2 |
111,388,509 |
| Subtract“E” Note: number must be same as shown in Step 3 |
0 |
| Total[“A” x 0.10] – “E” | 111,388,509 Note: this is the remaining placement capacity under rule 7.1A |
- See chapter 19 for defined terms.
Appendix 3B Page 13
04/03/2013
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity GLOBAL GEOSCIENCE LIMITED
ABN 76 098 564 606
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director Bernard Anthony Rowe
Date of last notice 24[th] April 2017
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect / Direct |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Lydail Pty Limited; Mopti Pty Limited, Mopti Management Pty Limited are controlled by BA Rowe. Venetia Francena Rowe –wife of BA Rowe |
| Date of change | 8th September 2017 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | BA Rowe – 58,334 ordinary shares Mopti Pty Limited – 42,791,402 ordinary shares Mopti Pty Limited – 1,000,000 unlisted options (exercisable at $0.047, expiring 30 DEC 2017) Venetia F. Rowe – 131,250 ordinary shares Mopti Management Pty Limited – 5,826,182 ordinary shares Bernard Anthony Rowe – 1,000,000 unlisted options, exp 30 Dec 2017, ex $0.07 Lydail Pty Limited – 387,698 ordinary shares Mopti Pty Limited - 6,000,000 Class B Performance Rights 6,000,000 Class C Performance Rights |
|---|---|
| Class | Ordinary shares |
| Number acquired | Mopti Pty Limited - 6,000,000 ordinaryshares |
| Number disposed | - |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Valued at $0.20 per share, being the vesting condition of the Class B Performance Rights |
| No. of securities held after change | BA Rowe – 58,334 ordinary shares Mopti Pty Limited – 48,791,402 ordinary shares Mopti Pty Limited – 1,000,000 unlisted options (exercisable at $0.047, expiring 30 DEC 2017) Venetia F. Rowe – 131,250 ordinary shares Mopti Management Pty Limited – 5,826,182 ordinary shares Bernard Anthony Rowe – 1,000,000 unlisted options, exp 30 Dec 2017, ex $0.07 Lydail Pty Limited – 387,698 ordinary shares Mopti Pty Limited - 6,000,000 Class C Performance Rights |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Ordinary shares issued as a result of the milestones set for the Class B Performance Rights being met. |
|
|---|---|---|
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | - |
|---|---|
| Nature of interest | - |
| Name of registered holder (if issued securities) |
- |
| Date of change | - |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
- |
| Interest acquired | - |
| Interest disposed | - |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
- |
| Interest after change | - |
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
- |
| If prior written clearance was provided, on what date was this provided? |
- |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: GLOBAL GEOSCIENCE LIMITED
ABN: 76 098 564 606
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | PATRICK JAMES DYMOCK ELLIOTT |
|---|---|
| Date of last notice | 24thApril 2017 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | DIRECT / INDIRECT |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Panstyn Investments Pty Ltd; Yeronda Nominees Pty Ltd; Buxbas Pty Ltd; and Notvan Pty Ltd are controlled by PJD Elliott PatrickJames Dymock Elliott |
| Date of change | 8thSeptember 2017 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | Patrick James Dymock Elliott – 5,616,667 ordinary shares Panstyn Investments Pty Ltd - 3,034,996 ordinary shares Yeronda Nominees Pty Ltd – 6,703,393 ordinary shares Buxbas Pty Ltd - 33,333 ordinary shares Notvan Pty Ltd – 58,333 ordinary shares Patrick James Dymock Elliott – 1,000,000 unlisted options (exercisable $0.07, expiring 30 December 2017) Patrick James Dymock Elliott – 1,500,000 Class B Performance Rights 1,500,000 Class C Performance Rights |
|---|---|
| Class | Ordinary shares |
| Number acquired | Patrick James Dymock Elliott - 1,500,000 ordinary shares |
| Number disposed | - |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
Valued at $0.20 per share, being the vesting condition of the Class B Performance Rights |
| No. of securities held after change | Patrick James Dymock Elliott – 7,116,667 ordinary shares Panstyn Investments Pty Ltd - 3,034,996 ordinary shares Yeronda Nominees Pty Ltd – 6,703,393 ordinary shares Buxbas Pty Ltd - 33,333 ordinary shares Notvan Pty Ltd – 58,333 ordinary shares Patrick James Dymock Elliott – 1,000,000 unlisted options (exercisable $0.07, expiring 30 December 2017) Patrick James Dymock Elliott – 1,500,000 Class C Performance Rights |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Ordinary shares issued as a result of the milestones set for the Class B Performance Rights being met. |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | - |
|---|---|
| Nature of interest | - |
| Name of registered holder (if issued securities) |
- |
| Date of change | - |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
- |
| Interest acquired | - |
| Interest disposed | - |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
- |
| Interest after change | - |
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
|
| If prior written clearance was provided, on what date was this provided? |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3